Grøntvedt Biotech is a Norwegian vertically integrated biotech company developing high-quality marine ingredients derived from Norwegian Pelagic fish.
Grøntvedt Biotech is a spin-off from Grøntvedt Group, which has worked with pelagic fish since 1830. The company`s CETO3® product is a product with high levels of Omega-11 & Omega-3 from Norwegian Pelagic fish, which is being used in nutraceuticals and functional foods. Immediate processing secures an oil with unique sensory qualities. The company is based in Ørlandet, Norway, where the entire operation takes place.